Stacey Davis

Ms. Davis brings 25 years of entrepreneurial experience building teams and leading corporate and portfolio strategy to her role at Xilio, where she focuses on furthering the company’s corporate and business development strategy. Prior to Xilio, Ms. Davis held multiple commercial leadership roles at Novartis Oncology and was responsible for building and growing Novartis’ footprint in lung cancer and immuno-oncology. Prior to Novartis, Ms. Davis was the senior vice president and general manager of Prominex, a start-up incubated through Roka Biosciences. She also held roles of increasing responsibility at several Johnson & Johnson businesses including Janssen Immunology, Ortho Clinical Diagnostics, and Johnson & Johnson Development Corp. Before joining Johnson & Johnson, Ms. Davis worked in strategic consulting at The Carson Group and in investment banking at Merrill Lynch. Ms. Davis received her B.S.E. in biomedical engineering from Duke University.